Nav: Home

Compound offers prospects for preventing acute kidney failure

September 09, 2019

Russian researchers from the Moscow Institute of Physics and Technology, the Institute of Cell Biophysics, and elsewhere have shown an antioxidant compound known as peroxiredoxin to be effective in treating kidney injury in mice. The study in Cell and Tissue Research reports tripled survival rates in test animals treated with the chemical prior to sustaining an ischemia-reperfusion injury. The team says peroxiredoxin also offers prospects for longer kidney transplant storage.

Ischemia-reperfusion causes kidney failure

Living tissues rely on a constant inflow of blood for survival. Restrictions in blood supply, known as ischemia, lead to a shortage of oxygen and nutrients. This may make the tissue more acidic and impair cell membrane permeability. Ultimately, tissue damage can arise, with the kidney, heart, and nerve tissues being the most vulnerable.

When normal blood inflow resumes, this so-called reperfusion does not cause the damaged tissue to regenerate. Instead, the concentration of reactive oxygen species grows, bringing about oxidative stress and further harming the cells. A pathologically high ROS count may trigger the cells to self-destruct in what is known as apoptosis.

The causes of ischemia include blood vessel constriction, changes in blood pressure or heart rate, loss of blood, and trauma. The ischemia-reperfusion syndrome remains a key factor in organ pathologies. When it affects the kidneys, acute renal failure may occur, resulting in death in half of the cases.

Antioxidants offer treatment options

Since oxidative stress is involved in the tissue damage under ischemia-reperfusion, antioxidants are a particularly promising treatment option. These are compounds that reduce oxidative stress by lowering ROS concentration.

In their recent study, the Russian researchers used antioxidant enzymes from the peroxiredoxins family. In addition to being involved in cell signaling, they reduce the level of the ROSs called peroxides. Among the six known enzymes in this family, peroxiredoxin 6 -- aka PRDX6 -- has the greatest appeal. Shown in figure 1, it has the capacity to neutralize the largest number of peroxides, both organic and inorganic.

Peroxiredoxin 6 boosts mouse survival

To prove the efficiency of the enzyme in kidney ischemia-reperfusion treatment, the researchers modeled this injury in mice and compared the survival rates of the animals that received PRX6 treatment and those that did not. In the latter group, 1 in 5 mice survived by day four, compared with 3 in 5 mice alive by that time in the group that received a PRX6 infusion 15 minutes prior to ischemia.

The induced ischemia-reperfusion in untreated mice was accompanied by edema, blood-engorged vessels in the kidneys, renal tubule degeneration, as well as an increased concentration of kidney damage markers and the transcription factors responsible for inflammation development. By contrast, the kidneys of the test animals receiving PRX6 displayed much smaller changes of pathological and morphological nature.

To rule out the possibility that the benefits of PRX6 are not related to peroxide suppression, the team synthesized a mutant version of the enzyme. It has the same structure, yet it does not affect peroxide levels. Administering the mutant enzyme 15 minutes before ischemia had no positive effect on mice survival. It is thus the compound's ability to keep peroxides in check that gives rise to its therapeutic effect.

The study's senior author Mars Sharapov of MIPT and the Institute of Cell Biophysics commented on the team's findings: "We observed the intravenously infused PRX6 in the animals' bloodstream, under kidney ischemia-reperfusion. That is, it did not enter the cells. Despite this, PRX6 effectively neutralized the peroxides that were released by the cells into the extracellular environment. This suppressed oxidative stress and apoptotic cell death, resulting in significantly less tissue damage."
-end-
The team working on the study featured researchers from MIPT, the Institute of Cell Biophysics of the Russian Academy of Sciences, and the Research Institute of Human Morphology of the Russian Academy of Medical Sciences.

Moscow Institute of Physics and Technology

Related Enzyme Articles:

First artificial enzyme created with two non-biological groups
Scientists at the University of Groningen turned a non-enzymatic protein into a new, artificial enzyme by adding two abiological catalytic components: an unnatural amino acid and a catalytic copper complex.
Enzyme may represent new target for treating asthma
An enzyme called diacylglycerol kinase zeta (DGKζ) appears to play an important role in suppressing runaway inflammation in asthma and may represent a novel therapeutic target.
Enzyme may indicate predisposition to cardiovascular disease
Study suggests that people with low levels of PDIA1 in blood plasma may be at high risk of thrombosis; this group also investigated PDIA1's specific interactions in cancer.
BridgIT, a new tool for orphan and novel enzyme reactions
Chemical engineers at EPFL have developed an online tool that can accurately assign genes and proteins to unknown 'orphan' reactions, which are a major headache for biotechnology, drug development, and even medicine.
How a mitochondrial enzyme can trigger cell death
Cytochrome c is a small enzyme that plays an important role in the production of energy by mitochondria.
Novel enzyme discovered in intestinal bacteria
At the University of Konstanz, in cooperation with Harvard University, a key enzyme for formation of harmful hydrogen sulphide in the human gut by Bilophila bacteria has been discovered.
Chemists discover unexpected enzyme structure
MIT chemists have discovered a unique aspect of the structure of carbon monoxide dehydrogenase, a bacterial enzyme that can convert carbon dioxide to carbon monoxide.
A human enzyme can biodegrade graphene
Graphene Flagship partners discovered that a natural human enzyme can biodegrade graphene.
Enzyme discovery could help in fight against TB
Research by a team led by Dr. Elizabeth Fullam has revealed new findings about an enzyme found in Mycobacterium tuberculosis (Mtb), the bacterium that causes TB.
Researchers discover new enzyme paradigm for critical reaction researchers discover new enzyme paradigm for critical reaction in converting lignin to useful produce useful products
An international research team, including scientists from the US Department of Energy's (DOE's) National Renewable Energy Laboratory (NREL), has discovered and characterized a new family of cytochrome P450 enzymes that is critical to improving the conversion of lignin--one of the main components of plants--into valuable products such as nylon, plastics, and chemicals.
More Enzyme News and Enzyme Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#555 Coronavirus
It's everywhere, and it felt disingenuous for us here at Science for the People to avoid it, so here is our episode on Coronavirus. It's ok to give this one a skip if this isn't what you want to listen to right now. Check out the links below for other great podcasts mentioned in the intro. Host Rachelle Saunders gets us up to date on what the Coronavirus is, how it spreads, and what we know and don't know with Dr Jason Kindrachuk, Assistant Professor in the Department of Medical Microbiology and infectious diseases at the University of Manitoba. And...
Now Playing: Radiolab

Dispatch 1: Numbers
In a recent Radiolab group huddle, with coronavirus unraveling around us, the team found themselves grappling with all the numbers connected to COVID-19. Our new found 6 foot bubbles of personal space. Three percent mortality rate (or 1, or 2, or 4). 7,000 cases (now, much much more). So in the wake of that meeting, we reflect on the onslaught of numbers - what they reveal, and what they hide.  Support Radiolab today at Radiolab.org/donate.